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Purpose: Indigofera tinctoria Linn. of the Fabaceae family is claimed to be useful in the treatment of a 
variety of epileptic disorders in Indian traditional system of medicine. The present study was designed to 
verify this claim. 
Methods: Status epilepticus was induced in male albino rats of Wistar strain by administration of 
pilocarpine (30 mg/kg, i.p.) 24 h after injection of lithium chloride (3 mEq/kg, i.p.).  Different doses of the 
ethanol extract of Indigofera tinctoria were administered orally 1 h before the injection of pilocarpine. 
The severity of status epilepticus was observed and recorded every 15 min for 90 min and thereafter 
every 30 min for another 90 min, using Racine scoring system. In-vivo lipid peroxidation of rat brain 
tissue was measured in terms of the thiobarbiturate-reactive substances (TBARS). Both in-vitro free 
radical nitric oxide (NO) and 2-diphenyl-2-picryl hydrazyl (DPPH) scavenging activities of the extract 
were also determined. 
Results: The severity of status epilepticus was significantly (p < 0.01) reduced following oral 
administration of the extract at 500 and 1000 mg/kg doses. No test animal group exhibited stage 4 
seizure. The extract also exhibited both in-vivo and in-vitro antioxidant activities. . 
Conclusion: The ethanol extract of Indigofera tinctoria was found to be useful in controlling 
lithium/pilocarpine-induced status epilepticus in albino rats. 
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INTRODUCTION 
 
Convulsive status epilepticus is a 
neurological emergency associated with high 
morbidity and mortality. It is defined as a 
condition in which there is either more than 
30 min of continuous seizure activity, or two 
or more sequential seizures without recovery 
of full consciousness between the seizures 
[1]. Convulsive status epilepticus is one of the 
dysfunctions of the nervous system and up to 
5% of the world population develops 
convulsions in their lifetime [2]. The principal 
causes of the condition are abrupt 
antiepileptic drug (AED) withdrawal or 
inappropriate switches of AED treatment, 
cerebrovascular disease, febrile illness, 
central nervous system (CNS) infections, 
CNS malignancy, metabolic disorders and 
drug toxicity. The first line of drugs in the 
management includes benzodiazepines, 
phenytoin and phenobarbital. Second line 
drugs include intravenous anaesthetics such 
as barbiturates, ketamine and propofol [3]. 
 
According to the World Health Organization, 
more than one billion people rely on plant and 
traditional medicines worldwide for the 
treatment of chronic ailments [4]. During the 
1950s, there was a major development in 
clinical neuropharmacology and 
psychopharmacology when plant drugs such 
as Acorus calamus [5] and Convolvulus 
pluricaulis [6] were discovered for some CNS 
disorders such as epilepsy, psychosis, 
depression and anxiety [7]. Only a few drugs 
have been approved by regulatory authorities 
to treat multi-factorial ailments of the CNS. 
Natural products have played a significant 
role in the management of neuropsychiatric 
disorders. Medicinal plants such as Centella 
asiatica [8] and Withania somnifera [9] from 
India have been shown to possess activity by 
modern methods of neuropharmacology. 
Several plants used for the treatment of 
epilepsy in different systems of traditional 
medicine have shown activity when tested by 
modern bioassay methods, but many of such 
plants remain to be further investigated.  
Increased oxidative stress has a role in the 
pathogenesis of coronary heart disease, 
neurodegenerative diseases, arthritis, 
epilepsy, cataract formation and immune 
system dysregulation. Enzymes and other 
small molecular antioxidants can protect 
experimental animals from the harmful effects 
of free radicals. The level of oxidative stress 
is used to identify an animal at risk for the 
development of the disease, or to monitor 
therapies directed at the disease. An 
increase in lipid peroxidation and excessive 
free radical formation occur during status 
epilepticus induced by pilocarpine [10]. 
 
Pilocarpine-induced status epilepticus model 
has provided information on the behavioral 
and neurochemical characteristics associated 
with seizure activity. The model has 
demonstrated permanent changes in different 
biochemical systems during status epilepticus 
[11]. Despite the availability of a large 
number of antiepileptics, current treatment is 
far from satisfactory. Approximately 30 % of 
patients continue to have seizures with 
current antiepileptic drug therapy [12]. Thus, 
there is a need to evaluate newer, more 
effective and safer agents for the treatment of 
epilepsy. Medicines of plant origin are 
relatively non-toxic, safe and easily available 
at lower costs. Indigofera tinctoria, of the 
Fabaceae family, is claimed to be an 
antiepileptic according to the Indian 
indigenous system of medicine. The plant is 
used extensively by Indian practitioners of 
traditional medicine in the control of epilepsy. 
Systematic pharmacological studies have not 
been carried out to support its use. The 
present study was, therefore, carried out to 
evaluate the plant’s effect on status 






The whole plant of Indigofera tinctoria was 
collected locally near Srinivasa Mangapuram 
area, Tirupati, Chittoor District, Andhra 
Pradesh, India in the month of June–July 
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according to its seasonal availability. The 
plant was authenticated by Professor T 
Vedavathi of the Department of Botany, Sri 
Venkateswara Arts and Science College, 
Tirupati, India. A voucher specimen was 
deposited at the herbarium of the Institute of 
Pharmaceutical Technology, A Women’s 
University, Tirupati, India (ref. no.: 02/IT/08-
IPT-SPMVV/TPT/2004). 
 
Drugs and chemicals 
 
Pentylenetetrazole (PTZ), pilocarpine nitrate 
and artificial cerebrospinal fluid (ACSF) were 
purchased from Sigma-Aldrich, USA. Lithium 
chloride, HPLC grade chemicals and solvents 
of analytical grade were purchased from SD 
Fine Chem, Mumbai, India. Diazepam was 
obtained from Ranbaxy, New Delhi, India. 
 
Plant extract  
 
The plant material was shade-dried at room 
temperature in the laboratory, powdered and 
passed through a 250µ aperture sieve. A 
quantity (200 g) of the plant powder was 
extracted with 1000 ml of 95 % ethanol under 
reflux by heating over a water bath. The 
extracts were then vacuum-dried. The yield of 
the extract was 28.2 %. Suspensions of the 
extract were prepared with 2 % Tween 80 




Male albino rats of Wistar strain weighing 150 
– 200 g were used for the study. They were 
housed in polypropylene cages and 
maintained under standard laboratory 
conditions with a 12−12 h light–dark cycle 
and as well as free access to standard rat 
pellet diet (Lipton, India Ltd.) and drinking 
water. They were acclimatized to laboratory 
conditions for 10 days before starting the 
experiment. The experimental protocol was 
approved by the institutional animal ethical 
committee (ref. no: 1220/a/08/CPCSEA). 
 
Acute toxicity and gross behavioral 
changes 
 
The extract used in this study was subjected 
to acute toxicity studies. The rats were fasted 
overnight with free access to drinking water 
and divided into six groups, each containing 
six animals. Group 1 animals served as 
control and received distilled water orally (2 
ml/kg). Animals in Groups 2 to 6 received 
0.25, 0.5, 1.0, 2.0 and 4.0 g/kg, respectively, 
of the extract orally by gastric intubation 
using a soft rubber catheter. The animals 
were observed continuously for 2 h and then 
intermittently at one-hourly interval until 24th 
hour, their behavioural, neurological and 
autonomic profiles were noted. The animals 
were observed for mortality up to the 48th 
hour. 
 
Induction of Status epilepticus 
 
Thirty rats were divided randomly into 5 
groups (n = 6). Group 1 animals (control) 
were administered distilled water (2.0 ml/kg, 
oral). Group 2 animals (reference standard) 
were treated with diazepam (2.0 mg/kg, i.p.) 
while Groups 3 – 5 animals were 
administered 250, 500 and 1000 mg/kg orally 
of the extract, respectively. Twenty four hours 
prior to treatment, all the rats received lithium 
chloride (3 mEq/kg, i.p.). One hour after 
treatment, status epilepticus was induced to 
all the animals (including control group) by 
administering pilocarpine (30 mg/kg, i.p.). 
The severity of status epilepticus was 
observed and recorded every 15 min until the 
90th min and thereafter every 30 min until 
180th min, using Racine [13] scoring system: 
0 (no response); 1 (fictive scratching); 2 
(tremors); 3 (head nodding); 4 (forelimb 
clonus) and 5 (rearing and fall back). 
 
Effect of extract on brain lipid 
peroxidation  
 
Five groups were used (n = 6). Group 1 
animals (control) were administered distilled 
water (2.0 ml/kg, oral) while Group 2 animals 
were administered Pentylenetetrazole (PTZ, 
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70 mg/kg) subcutaneously as the reference 
standard. Groups 3 – 5 animals were 
administered 250, 500 and 1000 mg/kg of the 
extract orally.  One hour after administration 
of the extract, PTZ (70 mg/kg) was injected 
subcutaneously to all the animals in Groups 3 
− 5 animals. On observing onset of 
convulsions following the administration of 
PTZ, the animals (including control group) 
were sacrificed by decapitation. The brains 
were removed and immediately submerged in 
ice-cold artificial cerebrospinal fluid (ACSF). 
The tissues were then washed to remove 
blood, blotted with cotton wool to remove 
excess water and submerged in 5 ml of 
methanol. It was then homogenized using a 
glass Teflon homogenizer for 2 min and 
centrifuged at 10,000 rpm at −10 °C for 15 
min. The supernatant was assayed based on 
the reaction between malondialdehyde 
(MDA) and thiobarbituric acid (TBA). To a 10 
ml volumetric flask, 0.5 ml of supernatant of 
brain homogenate and 2.5 ml of TCA were 
added and kept aside. Fifteen minutes later, 
1.5 ml of TCA and 3 ml of TBA were added to 
the flask and then placed over a water bath 
for 30 min. The flask contents were shaken 
for 5 min and centrifuged at 2000 rpm for 15 
min. The optical density of the supernatant 
was read at 532 nm against a blank (i.e., 
reaction mixture without brain tissue fluid) in 
a Shimadzu UV3600 spectrophotometer. 
Lipid peroxidation levels were expressed as 
‘n’ moles of MDA formed/g of brain tissue 
which was computed from MDA standard 
curve.  
 
Determination of in-vitro scavenging of 
nitric oxide (NO)  
 
Nitric oxide (NO), generated as a result of 
decomposition of sodium nitroprusside in an 
aqueous medium, interacts with oxygen at 
physiological pH to produce nitrite ions, which 
are measured by using Griess reagent. The 
absorbance of the chromophore formed 
during the diazotization of nitrite with 
sulphanilamide and subsequent coupling with 
N-napthylethylenediamine was read at 546 
nm and referred to the absorbance of 
standard solution of potassium nitrite, treated 
the same way with Griess reagent. Clear 
solutions of the extract (0.1, 0.2, 0.4, 0.8 and 
1 µg/ml) were prepared. One millilitre of 
sodium nitroprusside (10 µM/L) in pH 7.7 
phosphate buffer was added to each tube 
containing the extract. The mixtures were 
incubated at 25 °C for 2 h. An aliquot of 0.5 
ml of the incubation solution was diluted with 
0.5 ml of Griess reagent. Absorbance was 
measured spectrophotometrically at 546 nm. 
Ascorbic acid was used as a positive control. 
 
Determination of free radical 2-diphenyl-2-
picryl hydrazyl (DPPH) scanvenging 
activity of extract 
 
This assay is based on the measurement of 
the scavenging ability of a test substance 
against the stable radical. The free radical 
scavenging activity of the extract was 
examined in-vitro using DPPH radical. 
Different concentrations of the extract (0.1 − 
1 µg/ml were added to 100 µg DPPH/ml of 
ethanol and the tubes were maintained at 
ambient temperature for 20 min and the 
absorbance was measured 
spectrophotometrically at 517 nm. Ascorbic 




The data were expressed as mean ± S.E.M. 
Statistica (StatSoft Inc.) version 6.0 was used 
to analyze the data. ANOVA was used for 
multiple comparisons followed by Tukey–
Krammer test. In addition lithium-pilocarpine-
induced seizures were analyzed using 
Kruskal-Wallis ANOVA followed by Dunnet’s 





Acute toxicity and gross behavioural 
changes  
 
The extract of I. tinctoria did not provoke any 
gross behavioral changes or manifestations 
of toxic symptoms in the animals such as 
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weight loss, increased motor activity, tremors, 
clonic convulsions, tonic extensions, muscle 
spasm, spasticity, loss of right reflex, 
decreased motor activity, ataxia, sedation, 
muscle relaxation, hypnosis, arching and 
rolling, lacrimation, salivation, viscid, watery 
diarrheoa, writhing and urination over a 
period of 24 h. Ethanolic extract of I. tinctoria 
was nonlethal even at the maximum single 
oral dose of 4.0 g/kg. Hence, the oral doses 
of the extracts selected for the study were 
250, 500 and 1000 mg/kg. 
 
Effect of extract on lithium-pilocarpine 
induced Status epilepticus 
 
The results of the anti-epileptic activity of the 
extract are shown in Table 1. All the animals 
in the control group exhibited stage 4 
seizures within 45 min after pilocarpine 
injection. Group 2 animals pre-medicated 
with the reference standard drug (diazepam) 
did not demonstrate stage 2 seizures or 
beyond. The extract was able to diminish the 
intensity of seizures in all test groups of 
animals and none of the animals exhibited 
stage 4 seizures. In the extract-treated 
animals, a significant (p < 0.01, p < 0.001) 
reduction in the severity of lithium–pilocarpine 
induced status epilepticus was observed at 
oral doses of 500 and 1000 mg/kg, 
respectively. The animals were almost 
normal in behavior after 180 min.  
 
Effect of extract on brain lipid 
peroxidation  
 
The results for brain lipid peroxidation are 
presented in Table 2. The extract showed 
significant (p < 0.001) dose-dependent 
decrease in malondialdehyde (MDA) content 
in the test group animals of 9.2, 13.8 and 
18.4 % at oral doses of 250, 500 and 1000 
mg/kg, respectively when compared to the 
control group. 
 
In-vitro antioxidant activity 
 
The results of the antioxidant activity of the 
extract against NO and DPPH are expressed 
in Table 3. The extract exhibited a significant 
(p < 0.001)  concentration-dependent in-vitro 
 
Table 1: Effect of the extract of I. tinctoria on lithium-pilocarpine-induced Status epilepticus 
 
 
*p<0.01, **p<0.001, compared to control 
















15 1.5±0.20 0.50±0.45 1.40±0.45 0.00±0.00* 0.00±0.00* 
30 3.00±0.49 0.50±0.82** 2.00±0.30 1.00±0.20* 0.00±0.00* 
45 3.80±0.20 0.70±0.20** 2.50±0.30 1.00±0.10* 1.00±0.85* 
60 4.00±0.07 1.00±0.30* 3.00±0.55 2.10±0.10 1.50±0.09* 
75 4.50±0.20 1.00±0.40* 3.80±0.20 2.00±0.20* 2.00±0.48* 
90 5.00±0.88 1.50±0.22** 3.50±0.30 2.00±0.10* 1.50±0.95* 
120 3.80±0.20 1.00±0.21* 3.00±0.20 2.00±0.20 1.00±0.10* 
150 2.00±0.05 0.50±0.32* 2.00±0.41 1.30±0.10 0.00±0.00* 
180 1.00±0.68 0.20±0.11** 1.00±0.39 0.50±0.10 0.00±0.00* 
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1 Control (2 ml)  0.87±0.62 0.00 
2 PTZ 70 1.82±0.24 -109.20 
3 EEIT+PTZ 250 0.79±0.53* 9.20 
4 EEIT+PTZ 500 0.75±0.64* 13.80 
5 EEIT+PTZ 1000 0.71±0.53* 18.40 
 
*p<0.001, compared to control group 
 
Table 3: In-vitro free radical scavenging activity of the extract of I. tinctoria   
 
NO levels (µg/ml) DPPH levels (µg/ml) Extract concentration 
(µg/ml) Ascorbic acid   Extract Ascorbic acid  Extract 
0.1 3.6±0.51 14.24±1.64* 5.90±0.85 5.71±0.74 
0.2 12.7±1.02 24.15±2.18* 13.50±1.12 11.72±1.16 
0.4 30.8±4.01 29.82±3.75* 29.51±3.24 19.42±3.12* 
0.8 61.25±7.25 37.10±3.56* 62.15±5.96 37.68±4.49* 
1 75.1±9.36 44.29±4.18* 78.12±8.23 47.45±4.10* 
 
* p < 0.001, compared to ascorbic acid 
 
antioxidant activity against NO scavenging at 
all (0.1-1 µg/ml) test concentrations when 
compared with antioxidant activity of ascorbic 
acid, a positive control. The ethanolic extract 
of Indigofera tinctoria did not show significant 
in-vitro antioxidant activity against stable free 
radical 2-diphenyl-2-picryl hydrazyl (DPPH) 
scavenging at 0.1 and 0.2 µg/ml 
concentrations, but it has demonstrated a 
significant (p<0.001) in-vitro antioxidant 
activity against DPPH at concentrations, 0.4, 
0.8 and 1 µg/ml when compared to ascorbic 




Epilepsy is a common chronic neurological 
disorder which imposes a burden on health 
care systems. It is a manifestation of a variety 
of diseases with variable mortality. Deaths 
could be due to the causative etiology itself, 
such as tumours, degenerative conditions or 
cerebrovascular diseases. Evidence indicates 
that the imbalance between excitatory and 
inhibitory neurotransmission in the brain is 
the main cause or seizure development in 
both experimental and clinical situations [14].  
Pilocarpine-induced seizures, is one of the 
most frequently used model for temporal lobe 
epilepsy. In this model, lithium does not have 
proconvulsant effect in animals. However, 
animals pretreated with lithium have limbic 
seizures, following subconvulsant doses of 
pilocarpine. The combined effect of lithium–
pilocarpine results in the accumulation of 
acetylcholine, inositol monophosphate and 
reduction in cortical inositol − about ten times 
greater than the effects obtained with either 
drug alone [15]. Our study revealed that the 
ethanol extract of I. tinctoria exhibited dose-
dependent reduction in the severity of lithium-
pilocarpine induced status epilepticus. 
Lithium-pilocarpine induced status epilepticus 
correlates with both electrophysiological and 
neuropathological characteristics of temporal 
lobe epilepsy [16]. Hence, active principles 
from this plant may be useful in temporal lobe 
epilepsy. 
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Oxidative stress in the central nervous 
system has been shown in several rodent 
models of experimental epilepsy such as the 
PTZ-induced seizures model [17]. PTZ may 
also trigger a variety of biochemical 
processes including the activation of 
membrane phospholipases, proteases and 
nucleases. Alteration in the membrane 
phospholipid metabolism results in liberation 
of free fatty acids, diacylglycerols, 
eicosanoids, lipid peroxides and free radicals 
[18]. The extract of I. tinctoria exhibited 
significant free radical scavenging activity 
against NO and DPPH and also reduced the 
levels of brain MDA.  
 
Medicinal herbs with antioxidants are useful 
in diseases in which free radicals are 
involved, such as anoxia, ischemia of brain 
and epileptic neuronal damage, 
arteriosclerosis, rheumatic disorders and 
cancer [19, 20]. Several studies on medicinal 
plants with free radical scavenging and 
antioxidant activities indicate that these 
activities are due to the presence of 
polyphenols and flavonoids [21]. Earlier 
chemical studies indicate the presence of 
phenolic compounds and flavonoids in I. 
tinctoria [22]. Hence, the antioxidant and free 
radical scavenging activities of the plant may 
be due to the presence of these compounds 
which are known to exert antioxidant effects. 
 
Status epilepticus and oxidative stress are 
thought to be closely interrelated [23]. In the 
present study, lipid peroxidation and nitrite 
levels increased after status epilepticus. Lipid 
peroxidation is an index of irreversible 
neuronal damage of cell membrane 
phospholipid and has been suggested as a 
possible mechanism of epileptic activity [24]. 
A steady-state balance between the 
production of nitric oxide and metabolites and 
their destruction by antioxidant systems is 
present at normal conditions. The results of 
the present study show an increase in nitrite 
formation after status epilepticus, suggesting 
that there is a possible increase in 
concentrations of reactive oxygen species 
(ROS), which are often involved in neuronal 
damage. Pilocarpine induces status 
epilepticus, which can produce alterations in 
superoxide activity in different areas, thereby 
causing neuronal damage. Pilocarpine-
induced status epilepticus produces several 
changes in variables related to the generation 
and elimination of oxygen free radicals in 
adult rats [25]. In addition, in the normal 
physiological state, changes in neuronal 
activity are accompanied by alterations in the 
metabolic rate, which induce modifications in 
cerebral blood flow. In pathological states, 
changes in the blood flow may not occur in 
the same way. There is clinical and 
experimental evidence of reduced oxygen 
availability after status epilepticus. Evidence 
for the role of free radicals in status 
epilepticus is based on the use of enzymatic 
and non-enzymatic antioxidant treatment for 
protection against seizures and for status 




Results based on the lithium-pliocarpine 
induced status epilepticus rat model 
demonstrated that the ethanol extract of 
Indigofera tinctoria is effective in reducing the 
severity of status epilepticus. This, therefore, 
supports the traditional use of the plant in the 
treatment of epilepsy. The extract also 
possesses both in-vitro and in-vivo 
antioxidant activities. Further studies are 
required to isolate the compounds 
responsible for the extract’s activities and as 
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